NDC 57926-463 - Salix
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 57926-463
- Package NDCs from labels
- 57926-463-30
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2025-10-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Salix ® (furosemide tablets) | Merck Sharp & Dohme Corp. | 2025-10-30 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57926-463-30 | Salix | 500 in 1 BOTTLE | TABLET | 500 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Furosemide | ACTIVE INGREDIENT | 7LXU5N7ZO5 | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 | |
| Furosemide | ACTIVE MOIETY | 7LXU5N7ZO5 | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 | |
| FD&C Yellow No. 5 | INACTIVE INGREDIENT | I753WB2F1M | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 | |
| Lactose Monohydrate | INACTIVE INGREDIENT | EWQ57Q8I5X | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 | |
| Starch, Corn | INACTIVE INGREDIENT | O8232NY3SJ | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | c5db4434-0b47-038c-e053-2995a90ad7fe | 2024-01-28 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | c5db2be1-088f-1110-e053-2a95a90acac8 | 2024-01-22 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | 7b9af6a4-e1da-eb95-e053-2991aa0a031d | 2024-01-22 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Medical Purchasing Solutions, LLC | 0aab9759-ee48-d1d3-e063-6394a90a2741 | 2024-01-15 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | DIRECT RX | 9ec7808e-9201-4b8c-9790-d329320dc6c4 | 2024-01-09 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 6c2ee3a4-afea-4e1f-84e6-def0221ad437 | 2024-01-02 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 60cf5e60-9a7a-42c2-95b5-016f7a68ffc4 | 2023-12-18 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Medical Purchasing Solutions, LLC | 0a105e0b-b5cc-d929-e063-6294a90a80af | 2023-11-13 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | a2e46e16-4adf-4599-b69d-a6f6f891ba75 | 2023-10-31 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 020bc039-9e99-4895-96f8-0c6a556d3e67 | 2023-10-04 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | I753WB2F1M |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | I753WB2F1M |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | I753WB2F1M |
| Anubis Barcelona Regul OIl | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ARCTIUM MAJUS ROOT EXTRACT | ANUBIS COSMETICS SL | eb905bd0-c600-b8b2-e053-2995a90ad259 | 2023-09-01 | Warnings | I753WB2F1M |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, GLYCERYL STEARATE SE, HUMULUS LUPULUS (HOPS) CONE EXTRACT | ANUBIS COSMETICS SL | eb7c418b-8bee-26a3-e053-2a95a90a4e96 | 2023-09-01 | Warnings | I753WB2F1M |
| FUROSEMIDE | FUROSEMIDE | Medical Purchasing Solutions, LLC | 6a2235e8-d488-2d43-e053-2991aa0aa485 | 2023-05-30 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | Medical Purchasing Solutions, LLC | 6947af02-f50b-7f9c-e053-2a91aa0a45cd | 2023-05-22 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Medical Purchasing Solutions, LLC | bbf03f9a-ae33-8da1-e053-2a95a90a3bdb | 2023-05-08 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Medical Purchasing Solutions, LLC | d8a064cc-c741-8b80-e053-2a95a90a364c | 2023-05-03 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Medical Purchasing Solutions, LLC | ea4ead7c-c798-2d85-e053-2a95a90ab0b0 | 2023-04-24 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.